{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:10:57Z","timestamp":1792725057500,"version":"4.5.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.rpth.2024.102539","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T17:55:54Z","timestamp":1722880554000},"page":"102539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["How to undertake procedures while on antiplatelet agents: a hematologist's view"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1374-7333","authenticated-orcid":false,"given":"Dawn","family":"Swan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Douketis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jecko","family":"Thachil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2024.102539_bib1","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","article-title":"The global burden of cardiovascular diseases and risk: a compass for future health","volume":"80","author":"Vaduganathan","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.rpth.2024.102539_bib2","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.rpth.2024.102539_bib3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/jama.2013.284692","article-title":"Smoking prevalence and cigarette consumption in 187 countries, 1980-2012","volume":"311","author":"Ng","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.rpth.2024.102539_bib4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/jech.2004.025684","article-title":"Trends in smoking behaviour between 1985 and 2000 in nine European countries by education","volume":"59","author":"Giskes","year":"2005","journal-title":"J\u00a0Epidemiol Community Health"},{"key":"10.1016\/j.rpth.2024.102539_bib5","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1161\/CIRCULATIONAHA.112.096156","article-title":"Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health and Nutrition Examination Survey, 2001 to 2010","volume":"126","author":"Gu","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2024.102539_bib6","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1136\/heartjnl-2016-309573","article-title":"Trends in the epidemiology of cardiovascular disease in the UK","volume":"102","author":"Bhatnagar","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.rpth.2024.102539_bib7","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.hlc.2022.06.667","article-title":"Prescribing trends and health care expenditure of P2Y12 prescriptions in Australia over the last decade. Heart","volume":"31","author":"Abrahams","year":"2022","journal-title":"Lung Circ"},{"key":"10.1016\/j.rpth.2024.102539_bib8","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1111\/j.1538-7836.2011.04456.x","article-title":"Management of patients with recently implanted coronary stents on dual antiplatelet therapy who need to undergo major surgery","volume":"9","author":"Savonitto","year":"2011","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102539_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.100619","article-title":"Management of bleeding and procedures in patients on antiplatelet therapy","volume":"39","author":"Swan","year":"2020","journal-title":"Blood Rev"},{"key":"10.1016\/j.rpth.2024.102539_bib10","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/jppr.1663","article-title":"Contemporary trends in antiplatelet prescription in Australia","volume":"50","author":"Tan","year":"2020","journal-title":"J\u00a0Pharm Pract Res"},{"key":"10.1016\/j.rpth.2024.102539_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/bjh.12107","article-title":"British Committee for Standards in Haematology. Guideline on the management of bleeding in patients on antithrombotic agents","volume":"160","author":"Makris","year":"2013","journal-title":"Br J Haematol"},{"issue":"Suppl 1","key":"10.1016\/j.rpth.2024.102539_bib12","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/bja\/aet402","article-title":"Perioperative management of antiplatelet therapy","volume":"111","author":"Oprea","year":"2013","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.rpth.2024.102539_bib13","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/vox.12537","article-title":"Oral antiplatelet therapy: impact for transfusion medicine","volume":"112","author":"Gremmel","year":"2017","journal-title":"Vox Sang"},{"key":"10.1016\/j.rpth.2024.102539_bib14","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nsb0895-637","article-title":"The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase","volume":"2","author":"Loll","year":"1995","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.rpth.2024.102539_bib15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0035-1564835","article-title":"Platelet physiology","volume":"42","author":"Gremmel","year":"2016","journal-title":"Semin Thromb Hemost"},{"issue":"Suppl","key":"10.1016\/j.rpth.2024.102539_bib16","doi-asserted-by":"crossref","first-page":"e326S","DOI":"10.1378\/chest.11-2298","article-title":"Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Douketis","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.rpth.2024.102539_bib17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rpth.2024.102539_bib18","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1161\/01.CIR.100.10.1043","article-title":"Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery","volume":"100","author":"Lee","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2024.102539_bib19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cjca.2016.09.008","article-title":"Canadian Cardiovascular Society guidelines on perioperative cardiac risk assessment and management for patients who undergo noncardiac surgery","volume":"33","author":"Duceppe","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.rpth.2024.102539_bib20","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1001\/jama.2013.278787","article-title":"Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents","volume":"310","author":"Hawn","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.rpth.2024.102539_bib21","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.jvir.2019.04.017","volume":"30","author":"Patel","year":"2019","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.rpth.2024.102539_bib22","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1161\/STROKEAHA.119.024995","article-title":"Cardiovascular risk scores to predict perioperative stroke in noncardiac surgery","volume":"50","author":"Wilcox","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.rpth.2024.102539_bib23","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1093\/eurheartj\/ehac270","article-title":"2022 ESC guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery","volume":"43","author":"Halvorsen","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rpth.2024.102539_bib24","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1161\/01.CIR.105.13.1529","volume":"105","author":"Eagle","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2024.102539_bib25","article-title":"Predictors of bleeding in the perioperative anticoagulant use for surgery evaluation study","volume":"9","author":"Tafur","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.rpth.2024.102539_bib26","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1538-7836.2010.03781.x","article-title":"Risk of stroke after surgery in patients with and without chronic atrial fibrillation","volume":"8","author":"Kaatz","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102539_bib27","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDra2200322","article-title":"Perioperative management of anticoagulant and antiplatelet therapy","volume":"2","author":"Douketis","year":"2023","journal-title":"NEJM Evid"},{"key":"10.1016\/j.rpth.2024.102539_bib28","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/bjh.14344","article-title":"British Committee of Standards for Haematology. Peri-operative management of anticoagulation and antiplatelet therapy","volume":"175","author":"Keeling","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2024.102539_bib29","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1093\/eurheartj\/ehac270","volume":"43","author":"Halvorsen","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rpth.2024.102539_bib30","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1016\/j.chest.2022.07.025","article-title":"Perioperative management of antithrombotic therapy: an American College of Chest Physicians clinical practice guideline","volume":"162","author":"Douketis","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.rpth.2024.102539_bib31","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/EJA.0000000000001600","article-title":"Regional anaesthesia in patients on antithrombotic drugs: joint ESAIC\/ESRA guidelines","volume":"39","author":"Kietaibl","year":"2022","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.rpth.2024.102539_bib32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/AAP.0000000000000683","volume":"43","author":"Narouze","year":"2018","journal-title":"Reg Anesth Pain Med"},{"key":"10.1016\/j.rpth.2024.102539_bib33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/AAP.0000000000000763","article-title":"Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine evidence-based guidelines (fourth edition)","volume":"43","author":"Horlocker","year":"2018","journal-title":"Reg Anesth Pain Med"},{"key":"10.1016\/j.rpth.2024.102539_bib34","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1056\/NEJMoa1401105","article-title":"Aspirin in patients undergoing noncardiac surgery","volume":"370","author":"Devereaux","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2024.102539_bib35","doi-asserted-by":"crossref","first-page":"237","DOI":"10.7326\/M17-2341","article-title":"Aspirin in patients with previous percutaneous coronary intervention undergoing noncardiac surgery","volume":"168","author":"Graham","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rpth.2024.102539_bib36","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1538-7836.2012.04641.x","article-title":"Reversal of the anti-platelet effects of aspirin and clopidogrel","volume":"10","author":"Li","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102539_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104491","article-title":"Impact of aspirin and clopidogrel interruption on platelet function in patients undergoing major vascular surgery","volume":"9","author":"Le Manach","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.rpth.2024.102539_bib38","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.curtheres.2014.02.002","article-title":"Recovery time of platelet function after aspirin withdrawal","volume":"76","author":"Lee","year":"2014","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.rpth.2024.102539_bib39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.acvd.2018.10.004","volume":"112","author":"Godier","year":"2019","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.rpth.2024.102539_bib40","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jcin.2017.10.051","article-title":"A\u00a0multidisciplinary approach on the perioperative antithrombotic management of patients with coronary stents undergoing surgery: surgery after stenting 2","volume":"11","author":"Rossini","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.rpth.2024.102539_bib41","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jcin.2009.03.014","article-title":"Characterization of post-operative risk associated with prior drug-eluting stent use","volume":"2","author":"Anwaruddin","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.rpth.2024.102539_bib42","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(15)00979-4","article-title":"Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials","volume":"387","author":"Cassese","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2024.102539_bib43","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","volume":"39","author":"Valgimigli","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rpth.2024.102539_bib44","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/01.CIR.0000140675.85342.1B","article-title":"Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial","volume":"110","author":"Fox","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2024.102539_bib45","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jacc.2010.10.029","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (platelet inhibition and patient outcomes) trial","volume":"57","author":"Held","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.rpth.2024.102539_bib46","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2024.102539_bib47","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1093\/eurheartj\/ehp296","article-title":"P2Y12 inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use","volume":"30","author":"Wallentin","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rpth.2024.102539_bib48","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1161\/CIR.0000000000000404","volume":"134","author":"Levine","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2024.102539_bib49","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/CIRCULATIONAHA.123.066720","article-title":"An aspirin-free versus dual antiplatelet strategy for coronary stenting: STOPDAPT-3 randomized trial","volume":"149","author":"Natsuaki","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2024.102539_bib50","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1001\/jama.2019.8145","article-title":"Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: the STOPDAPT-2 randomized clinical trial","volume":"321","author":"Watanabe","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.rpth.2024.102539_bib51","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1001\/jama.2020.7580","article-title":"Effect of ticagrelor monotherapy vs ticagrelor with aspirin on major bleeding and cardiovascular events in patients with acute coronary syndrome: the TICO randomized clinical trial","volume":"323","author":"Kim","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.rpth.2024.102539_bib52","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1056\/NEJMoa1908419","article-title":"Ticagrelor with or without aspirin in high-risk patients after PCI","volume":"381","author":"Mehran","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2024.102539_bib53","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMoa2108749","article-title":"Dual antiplatelet therapy after PCI in patients at high bleeding risk","volume":"385","author":"Valgimigli","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2024.102539_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0291061","article-title":"Short dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk patients: systematic review and meta-analysis","volume":"18","author":"Bainey","year":"2023","journal-title":"PloS One"},{"key":"10.1016\/j.rpth.2024.102539_bib55","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/practneurol-2017-001820","article-title":"Periprocedural antithrombotic management for lumbar puncture: Association of British Neurologists clinical guideline","volume":"18","author":"Dodd","year":"2018","journal-title":"Pract Neurol"},{"key":"10.1016\/j.rpth.2024.102539_bib56","first-page":"303","article-title":"Preoperative antiplatelet therapy does not increase the risk of spinal hematoma associated with regional anesthesia","volume":"80","author":"Horlocker","year":"1995","journal-title":"Anesth Analg"},{"key":"10.1016\/j.rpth.2024.102539_bib57","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(94)92633-6","article-title":"CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (collaborative low-dose aspirin study in pregnancy) collaborative group","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2024.102539_bib58","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/EJA.0b013e32833f6f6f","article-title":"European Scoeity of Anaesthesiology. Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology","volume":"27","author":"Gogarten","year":"2010","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.rpth.2024.102539_bib59","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.jacc.2021.08.013","article-title":"Bridging antiplatelet therapy after percutaneous coronary intervention: JACC review topic of the week","volume":"78","author":"Sullivan","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.rpth.2024.102539_bib60","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.amjcard.2012.04.016","article-title":"Safety of \u201cbridging\u201d with eptifibatide for patients with coronary stents before cardiac and non-cardiac surgery","volume":"110","author":"Rassi","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.rpth.2024.102539_bib61","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s11239-016-1441-5","article-title":"Bleeding risk associated with eptifibatide (Integrilin) bridging in thoracic surgery patients","volume":"43","author":"Waldron","year":"2017","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.rpth.2024.102539_bib62","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.vph.2015.11.085","article-title":"Bridge therapy or standard treatment for urgent surgery after coronary stent implantation: analysis of 314 patients","volume":"80","author":"De Servi","year":"2016","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.rpth.2024.102539_bib63","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/0091270009344986","article-title":"Pharmacokinetics and pharmacodynamics of a bolus and infusion of cangrelor: a direct, parenteral P2Y12 receptor antagonist","volume":"50","author":"Akers","year":"2010","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.rpth.2024.102539_bib64","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jama.2011.2002","article-title":"Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial","volume":"307","author":"Angiolillo","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.rpth.2024.102539_bib65","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1093\/eurheartj\/ehu282","volume":"35","author":"Kristensen","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rpth.2024.102539_bib66","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1253\/circj.CJ-19-1109","article-title":"JCS 2020 guideline focused update on antithrombotic therapy in patients with coronary artery disease","volume":"84","author":"Nakamura","year":"2020","journal-title":"Circ J"},{"key":"10.1016\/j.rpth.2024.102539_bib68","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1538-7836.2006.02245.x","article-title":"Normalization of platelet reactivity in clopidogrel-treated subjects","volume":"5","author":"Vilahur","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102539_bib69","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3109\/09537104.2015.1035247","article-title":"Impact of non-inhibited platelet supplementation on platelet reactivity in patients treated with prasugrel or ticagrelor for an acute coronary syndrome: an ex\u00a0vivo study","volume":"26","author":"Bonhomme","year":"2015","journal-title":"Platelets"},{"key":"10.1016\/j.rpth.2024.102539_bib70","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/01586154-201305000-00027","article-title":"Is platelet transfusion efficient to restore platelet reactivity in patients who are responders to aspirin and\/or clopidogrel before emergency surgery?","volume":"74","author":"Taylor","year":"2013","journal-title":"J\u00a0Trauma Acute Care Surg"},{"key":"10.1016\/j.rpth.2024.102539_bib71","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.115.002786","article-title":"Efficacy of ex\u00a0vivo autologous and in\u00a0vivo platelet transfusion in the reversal of P2Y12 inhibition by clopidogrel, prasugrel, and ticagrelor: the APTITUDE study","volume":"8","author":"O\u2019Connor","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.rpth.2024.102539_bib72","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1423-0410.2012.01595.x","article-title":"Prophylactic platelet transfusions","volume":"103","author":"Pietersz","year":"2012","journal-title":"Vox Sang"},{"key":"10.1016\/j.rpth.2024.102539_bib73","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/jth.12058","article-title":"Platelet function normalization after a prasugrel loading-dose: time-dependent effect of platelet supplementation","volume":"11","author":"Zafar","year":"2013","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102539_bib74","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005120","article-title":"Impact of timing on the functional recovery achieved with platelet supplementation after treatment with ticagrelor","volume":"10","author":"Zafar","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.rpth.2024.102539_bib75","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/phar.1477","article-title":"Ticagrelor: pharmacokinetics, pharmacodynamics, clinical efficacy, and safety","volume":"34","author":"Dobesh","year":"2014","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.rpth.2024.102539_bib76","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1055\/s-0038-1673381","article-title":"In\u00a0vitro reversal of the anti-aggregant effect of ticagrelor using untreated platelets","volume":"118","author":"Kruger","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2024.102539_bib77","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1056\/NEJMc1409373","article-title":"Inefficacy of platelet transfusion to reverse ticagrelor","volume":"372","author":"Godier","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2024.102539_bib78","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/jcpt.12130","article-title":"The effect of desmopressin on bleeding time and platelet aggregation in healthy volunteers administered ticagrelor","volume":"39","author":"Teng","year":"2014","journal-title":"J\u00a0Clin Pharm Ther"},{"key":"10.1016\/j.rpth.2024.102539_bib79","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1474-4422(23)00157-6","article-title":"Desmopressin for patients with spontaneous intracerebral haemorrhage taking antiplatelet drugs (DASH): a UK-based, phase 2, randomised, placebo-controlled, multicentre feasibility trial","volume":"22","author":"Desborough","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.rpth.2024.102539_bib80","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1161\/STR.0000000000000407","article-title":"2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association\/American Stroke Association","volume":"53","author":"Greenberg","year":"2022","journal-title":"Stroke"},{"key":"10.1016\/j.rpth.2024.102539_bib81","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/MBC.0000000000000511","article-title":"Boosting the coagulation restores haemostasis in ticagrelor-treated mice","volume":"27","author":"Pehrsson","year":"2016","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.rpth.2024.102539_bib82","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1006221","article-title":"Safety of recombinant activated factor VII in randomized clinical trials","volume":"363","author":"Levi","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2024.102539_bib83","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/EJA.0b013e32834050ab","article-title":"Tranexamic acid partially improves platelet function in patients treated with dual antiplatelet therapy","volume":"28","author":"Weber","year":"2011","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.rpth.2024.102539_bib84","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/jclinpath-2016-204117","article-title":"Ticagrelor reversal: in\u00a0vitro assessment of four haemostatic agents","volume":"70","author":"Calmette","year":"2017","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.rpth.2024.102539_bib85","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1161\/CIRCRESAHA.122.321034","article-title":"Platelet-mimicking nanosponges for functional reversal of antiplatelet agents","volume":"132","author":"Xu","year":"2023","journal-title":"Circ Res"},{"key":"10.1016\/j.rpth.2024.102539_bib86","first-page":"26","article-title":"Reducing antithrombotic-related bleeding risk in urgent and emergency cardiac surgery","volume":"28","author":"Harky","year":"2021","journal-title":"Br J Cardiol"},{"key":"10.1016\/j.rpth.2024.102539_bib87","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.jvca.2017.06.026","article-title":"2017 EACTS\/EACTA guidelines on patient blood management for adult cardiac surgery","volume":"32","author":"Boer","year":"2018","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.rpth.2024.102539_bib88","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/CIRCULATIONAHA.116.023956","article-title":"Point-of-care hemostatic testing in cardiac surgery: a stepped-wedge clustered randomized controlled trial","volume":"134","author":"Karkouti","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2024.102539_bib89","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1161\/CIRCULATIONAHA.111.031195","article-title":"Do platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents?: platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents","volume":"125","author":"Gurbel","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2024.102539_bib90","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1016\/j.jacc.2013.07.101","article-title":"Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding","volume":"62","author":"Tantry","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.rpth.2024.102539_bib91","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(13)61170-8","article-title":"Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study","volume":"382","author":"Stone","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2024.102539_bib92","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1161\/CIRCULATIONAHA.118.035160","article-title":"Is there a role for preoperative platelet function testing in patients undergoing cardiac surgery during antiplatelet therapy?","volume":"138","author":"Mahla","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.rpth.2024.102539_bib93","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCINTERVENTIONS.111.967208","volume":"5","author":"Mahla","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.rpth.2024.102539_bib94","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jtcvs.2013.12.011","article-title":"Individualized strategy for clopidogrel suspension in patients undergoing off-pump coronary surgery for acute coronary syndrome: a case-control study","volume":"148","author":"Mannacio","year":"2014","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.rpth.2024.102539_bib95","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1111\/jocs.16035","article-title":"The use of point-of-care testing in detecting platelet function recovery in a patient treated with prasugrel undergoing urgent surgical revascularization","volume":"36","author":"Verzelloni","year":"2021","journal-title":"J\u00a0Card Surg"},{"key":"10.1016\/j.rpth.2024.102539_bib96","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/ejcts\/ezx181","article-title":"Postoperative bleeding in coronary artery bypass patients on double antiplatelet therapy: predictive value\u00a0of\u00a0preoperative aggregometry","volume":"52","author":"Della Corte","year":"2017","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.rpth.2024.102539_bib97","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/icvts\/ivy336","article-title":"Postoperative platelet function is associated with severe bleeding in ticagrelor-treated patients","volume":"28","author":"Bj\u00f6rklund","year":"2019","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.rpth.2024.102539_bib98","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00228-021-03250-6","article-title":"Trends in the use of oral anticoagulants, antiplatelets and statins in four European countries: a population-based study","volume":"78","author":"Garc\u00eda Rodr\u00edguez","year":"2022","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037924002346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037924002346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T23:25:02Z","timestamp":1728602702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037924002346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":97,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2475037924002346"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2024.102539","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How to undertake procedures while on antiplatelet agents: a hematologist's view","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2024.102539","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"102539"}}